pharmaphorum November 19, 2021
US company Respira Labs has developed a device worn on the chest that uses tiny speakers and microphones to project sound into the lungs and listen for signals that could indicate serious lung diseases.
The Sylvee wearable uses an artificial intelligence (AI) algorithm to interpret sounds that may indicate trapped air in the lungs, which can be a sign of ill health, using acoustic resonance – similar to the way an ultrasound machine creates visual images.
The California company says the device can be used to remotely monitor patients with COVID-19, chronic obstructive pulmonary disease, and asthma, and may serve as an early warning system for exacerbations that could prevent costly hospital visits. More than 100 million Americans are affected...